This company listing is no longer active
0QEN Stock Overview
Coala-Life Group AB (publ) operates as a medical device company. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Coala-Life Group AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €0.029 |
52 Week High | €0.11 |
52 Week Low | €0.029 |
Beta | 1.02 |
1 Month Change | 0% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -99.86% |
Recent News & Updates
Recent updates
Shareholder Returns
0QEN | GB Medical Equipment | GB Market | |
---|---|---|---|
7D | 0% | 5.4% | 3.5% |
1Y | n/a | -7.2% | 10.5% |
Return vs Industry: Insufficient data to determine how 0QEN performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how 0QEN performed against the UK Market.
Price Volatility
0QEN volatility | |
---|---|
0QEN Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 6.7% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 10.9% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0QEN's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 0QEN's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 89 | Dan Pitulia | www.coalalife.com |
Coala-Life Group AB (publ) operates as a medical device company. The company develops medical innovations that enable long-term monitoring of patients in daily life, which supports diagnosis of heart and lungs and improve clinical outcomes. Its products offer healthcare providers diagnostic support by the ability to follow patient’s in everyday life.
Coala-Life Group AB (publ) Fundamentals Summary
0QEN fundamental statistics | |
---|---|
Market cap | SEK 283.57m |
Earnings (TTM) | -SEK 147.62m |
Revenue (TTM) | SEK 49.07m |
0.0x
P/S Ratio0.0x
P/E RatioIs 0QEN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
0QEN income statement (TTM) | |
---|---|
Revenue | SEK 49.07m |
Cost of Revenue | SEK 60.62m |
Gross Profit | -SEK 11.55m |
Other Expenses | SEK 136.07m |
Earnings | -SEK 147.62m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.10 |
Gross Margin | -23.55% |
Net Profit Margin | -300.87% |
Debt/Equity Ratio | 0% |
How did 0QEN perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/04/08 13:51 |
End of Day Share Price | 2024/02/14 00:00 |
Earnings | 2023/09/30 |
Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Coala-Life Group AB (publ) is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Erik Nordström | Redeye |